METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY

This application describes methods of treating alpha-1 antitrypsin deficiency (AATD) comprising administering Compound I, a deuterated derivative thereof, and/or a pharmaceutically acceptable salt thereof. The application also describes pharmaceutical compositions comprising Compound I, a deuterated...

Full description

Saved in:
Bibliographic Details
Main Authors HARE, BRIAN J, MARIGOWDA, GAUTHAM, TIAN, BOSHENG, PANORCHAN, PORNTULA, ZHANG, WEIYAN, BOZIC, CARMEN, CIRINCIONE, BRENDA, INGENITO, EDWARD, KUMAR, SANJEEV, RHEE, DAVID, STILES, DAVID KENT, PETERSON, MARK CHRISTOPHER
Format Patent
LanguageEnglish
French
Published 05.08.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This application describes methods of treating alpha-1 antitrypsin deficiency (AATD) comprising administering Compound I, a deuterated derivative thereof, and/or a pharmaceutically acceptable salt thereof. The application also describes pharmaceutical compositions comprising Compound I, a deuterated derivative thereof, and/or a pharmaceutically acceptable salt thereof. Cette invention concerne des procédés de traitement d'une déficience en Alpha-1 antitrypsine (AATD) comprenant l'administration du composé I, d'un dérivé deutéré de celui-ci, et/ou d'un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également des compositions pharmaceutiques comprenant le composé I, un dérivé deutéré de celui-ci, et/ou un sel pharmaceutiquement acceptable de celui-ci.
Bibliography:Application Number: CA20213168807